Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
US Army
Federal Trade Commission
Argus Health
Citi
Chinese Patent Office
Healthtrust
Baxter
Moodys

Generated: December 11, 2017

DrugPatentWatch Database Preview

Wyeth Pharms Pfizer Company Profile

« Back to Dashboard

What is the competitive landscape for WYETH PHARMS PFIZER, and when can generic versions of WYETH PHARMS PFIZER drugs launch?

WYETH PHARMS PFIZER has one approved drug.

There are five US patents protecting WYETH PHARMS PFIZER drugs.

There are sixty-two patent family members on WYETH PHARMS PFIZER drugs in forty countries and ten supplementary protection certificates in nine countries.

Summary for Wyeth Pharms Pfizer

International Patents:62
US Patents:5
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms PfizerDUAVEEbazedoxifene acetate; estrogens, conjugatedTABLET;ORAL022247-001Oct 3, 2013RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Wyeth Pharms PfizerDUAVEEbazedoxifene acetate; estrogens, conjugatedTABLET;ORAL022247-001Oct 3, 2013RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Wyeth Pharms PfizerDUAVEEbazedoxifene acetate; estrogens, conjugatedTABLET;ORAL022247-001Oct 3, 2013RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Wyeth Pharms PfizerDUAVEEbazedoxifene acetate; estrogens, conjugatedTABLET;ORAL022247-001Oct 3, 2013RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Wyeth Pharms PfizerDUAVEEbazedoxifene acetate; estrogens, conjugatedTABLET;ORAL022247-001Oct 3, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Wyeth Pharms PfizerDUAVEEbazedoxifene acetate; estrogens, conjugatedTABLET;ORAL022247-001Oct 3, 2013RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Wyeth Pharms PfizerDUAVEEbazedoxifene acetate; estrogens, conjugatedTABLET;ORAL022247-001Oct 3, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Wyeth Pharms Pfizer

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms PfizerDUAVEEbazedoxifene acetate; estrogens, conjugatedTABLET;ORAL022247-001Oct 3, 2013► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Wyeth Pharms Pfizer

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,835,729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents► Subscribe
7,247,6242-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents► Subscribe
6,127,404 Tissue selective compounds in the treatment of endometrial proliferation► Subscribe
6,924,281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents► Subscribe
7,449,4552-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents► Subscribe
6,951,852 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indoles as estrogenic agents► Subscribe
6,787,538 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents► Subscribe
6,291,451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents► Subscribe
7,041,6632-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents► Subscribe
6,326,367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Wyeth Pharms Pfizer Drugs

Country Document Number Estimated Expiration
Germany69707189► Subscribe
China1938272► Subscribe
Russian Federation2006132180► Subscribe
European Patent Office1732890► Subscribe
Japan4093611► Subscribe
Slovakia281737► Subscribe
Guatemala200500078► Subscribe
Norway20065052► Subscribe
Czech Republic291701► Subscribe
Japan2009035535► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Wyeth Pharms Pfizer Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2009007Lithuania► SubscribePRODUCT NAME: BAZEDOXIFENUM; REGISTRATION NO/DATE: EU/1/09/511/001 - EU/1/09/511/004 20090417
09/028Ireland► SubscribePRODUCT NAME: BAZEDOXIFENE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/09/511/001-004 20090417
C/GB09/045United Kingdom► SubscribePRODUCT NAME: BAZEDOXIFENE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/09/511/001 20090417; UK EU/1/09/511/002 20090417; UK EU/1/09/511/003 20090417; UK EU/1/09/511/004 20090417
2009007,C0802183Lithuania► SubscribePRODUCT NAME: BAZEDOXIFENUM; REGISTRATION NO/DATE: EU/1/09/511/001 - EU/1/09/511/004 20090417
608Luxembourg► Subscribe91608, EXPIRES: 20220415
C0048France► SubscribePRODUCT NAME: BAZEDOXIFENE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/09/511/001 DU 20090417; REGISTRATION NO/DATE AT EEC: EU/1/09/511/001-004 DU 20090417
0802183/01Switzerland► SubscribePRODUCT NAME: BAZEDOXIFEN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58732 12.01.2010
2009 00035Denmark► Subscribe
0416Netherlands► Subscribe300416, 20170415, EXPIRES: 20220414
4Finland► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
US Department of Justice
Federal Trade Commission
Daiichi Sankyo
Deloitte
Julphar
Farmers Insurance
UBS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot